Advertisement

Cognitive impairment in neuromyelitis optica spectrum disorders: What do we know?

Published:October 06, 2017DOI:https://doi.org/10.1016/j.msard.2017.10.003

      Abstract

      The aim of this study is to make a descriptive review of the bibliography available on cognitive dysfunction in patients with neuromyelitis optica spectrum disorders (NMOSD). We selected fifteen studies that quantitatively assess the relationship between NMOSD and one or more cognitive variables. Results showed that patients with NMOSD had a decrease in cognitive functions. Cognitive dysfunctions were found in 35–67% of patients with NMOSD, specifically in the attention, memory and information processing speed. Cognitive dysfunctions were found to relate to injuries in white matter as well as clinical variables and depression.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Blanc F.
        • Zephir H.
        • Lebrun C.
        • Labauge P.
        • Castelnovo G.
        • Fleury M.
        • de Seze J.
        Cognitive functions in neuromyelitis optica.
        Arch. Neurol. 2008; 65: 84-88https://doi.org/10.1001/archneurol.2007.16
        • Blanc F.
        • Noblet V.
        • Jung B.
        • Rousseau F.
        • Renard F.
        • Bourre B.
        • de Seze J.
        White matter atrophy and cognitive dysfunctions in neuromyelitis optica.
        PLoS One. 2012; 7: e33878https://doi.org/10.1371/journal.pone.0033878
        • Cáceres F.
        • Vanotti S.
        • Rao S.
        • The Reconem Workgroup
        Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country.
        J. Clin. Exp. Neuropsychol. 2011; 1: 1-5
        • Chanson J.B.
        • Ze´phir H.
        • Collongues N.
        • Outteryck O.
        • Blanc F.
        • Fleury M.
        • de Seze J.
        Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica.
        Eur. J. Neurol. 2011; 18: 836-841https://doi.org/10.1111/j.1468-1331.2010.03252.x
        • Charcot J.M.
        Lectures on the Diseases of the Nervous System Delivered at La Salpetriere.
        New Sydenham Society, London1887
        • Fan Y.
        • Liu M.
        • Wu X.
        • Wang F.
        • Ding J.
        • Chen J.
        • Hu H.
        Aquaporin-4 promotes memory consolidation in Morris water maze.
        Brain Struct. Funct. 2013; 218: 39-50https://doi.org/10.1007/s00429-011-0373-2
        • Flanagan E.P.
        • Weinshenker B.G.
        Neuromyelitis optica spectrum disorders.
        Curr. Neurol. Neurosci. Rep. 2014; 14: 483https://doi.org/10.1007/s11910-014-0483-3
        • He D.
        • Wu Q.
        • Chen X.
        • Zhao D.
        • Gong Q.
        • Zhou H.
        Cognitive impairment and whole brain diffusión in patients with neuromyelistis óptica after acute relapse.
        Brain Cognit. 2011; 77: 80-88https://doi.org/10.1016/j.bandc.2011.05.007
        • He D.
        • Chen X.
        • Zhao D.
        • Zhou H.
        Cognitive function, depression, fatigue, and activities of daily living in patients with neuromyelitis optica after acute relapse.
        Int. J. Neurosci. 2011; 121: 677-683https://doi.org/10.3109/00207454.2011.608456
        • Hollinger K.R.
        • Franke C.
        • Arenivas A.
        • Woods S.R.
        • Mealy M.A.
        • Levy M.
        • Kaplin A.I.
        Cognition, mood, and purpose in life in neuromyelitis optica spectrum disorder.
        J. Neurol. Sci. 2016; 15: 85-90https://doi.org/10.1016/j.jns.2016.01.010
        • Hyun J.W.
        • Park G.
        • Kwak K.
        • Jo H.J.
        • Joung A.
        • Kim J.H.
        • Kim H.J.
        Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
        Eur. J. Neurol. 2017; 24: 437-445https://doi.org/10.1111/ene.13224
        • Kanamori Y.
        • Nakashima I.
        • Takai Y.
        • Nishiyama S.
        • Kuroda H.
        • Takahashi T.
        • Itoyama Y.
        Pain in neuromyelitis optica and its effect on quality of life: a cross-sectionalstudy.
        Neurology. 2011; 77: 652-658https://doi.org/10.1212/WNL.0b013e318229e694
        • Kawahara Y.
        • Ikeda M.
        • Deguchi K.
        • Hishikawa N.
        • Kono S.
        • Omote Y.
        • Abe K.
        Cognitive and affective assessments of multiple sclerosis (MS) and neuromyelitis optica (NMO) patients utilizing computerized touch panel-type screening tests.
        Intern. Med. 2014; 53: 2281-2290https://doi.org/10.2169/internalmedicine.53.2571
        • Kim S.H.
        • Kwak K.
        • Jeong I.H.
        • Hyun J.W.
        • Jo H.J.
        • Joung A.
        • Kim H.J.
        Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
        Mult. Scler. 2016; (Epub ahead of print), doi: 1352458516636246.
        • Lennon V.A.
        • Wingerchuk D.M.
        • Kryzer T.J.
        • Pittock S.J.
        • Lucchinetti C.F.
        • Fujihara K.
        • Weinshenker B.G.
        A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
        Lancet. 2004; 364: 2106-2112
        • Liu Y.
        • Xie T.
        • He Y.
        • Duan Y.
        • Huang J.
        • Ren Z.
        • Li K.
        Cortical thinning correlates with cognitive change in multiple sclerosis but not in neuromyelitis optica.
        Eur. Radiol. 2014; 24: 2334-2343https://doi.org/10.1007/s00330-014-3239-1
        • Liu Y.
        • Fu Y.
        • Schoonheim M.M.
        • Zhang N.
        • Fan M.
        • Su L.
        • Shi F.D.
        Structural MRI substrates of cognitive impairment in neuromyelitis optica.
        Neurology. 2015; 85: 1491-1499https://doi.org/10.1212/WNL.0000000000002067
        • Meng H.
        • Xu J.
        • Pan C.
        • Cheng J.
        • Hu Y.
        • Hong Y.
        • Dai H.
        Cognitive dysfunction in adult patients with neuromyelitis optica: a systematic review and meta-analysis.
        J. Neurol. 2016; (Epub ahead of print)https://doi.org/10.1007/s00415-016-8345-3
        • Moore P.
        • Methley A.
        • Pollard C.
        • Mutch K.
        • Hamid S.
        • Elsone L.
        • Jacob A.
        Cognitive and psychiatric comorbidities in neuromyelitis optica.
        J. Neurol. Sci. 2016; 360: 4-9https://doi.org/10.1016/j.jns.2015.11.031
        • Pittock S.J.
        • Weinshenker B.G.
        • Lucchinetti C.F.
        • Wingerchuk D.M.
        • Corboy J.R.
        • Lennon V.A.
        Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
        Arch. Neurol. 2006; 63: 964-968
        • Saji E.
        • Arakawa M.
        • Yanagawa K.
        • Toyoshima Y.
        • Yokoseki A.
        • Okamoto K.
        • Kawachi I.
        Cognitive impairment and cortical degeneration in neuromyelitis optica.
        Ann. Neurol. 2013; 73: 65-76https://doi.org/10.1002/ana.23721
        • Scharfman H.E.
        • Binder D.K.
        Aquaporin-4 water channels and synaptic plasticity in the hippocampus.
        Neurochem. Int. 2013; 63: 702-711https://doi.org/10.1016/j.neuint.2013.05.003
        • Sepulcre J.
        • Vanotti S.
        • Hernandez R.
        • Sandoval G.
        • Caceres F.
        • Garcea O.
        • Villoslada P.
        Cognitive impairment in patients with multiple sclerosis using the brief repeatable battery-neuropsychology test.
        Mult. Scler. 2006; 12: 187-195
        • de Seze J.
        • Stojkovic T.
        • Ferriby D.
        • Gauvrit J.Y.
        • Montagne C.
        • Mounier-Vehier F.
        • Vermersch P.
        Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile.
        J. Neurol. Sci. 2001; 197: 57-61
        • Vanotti S.
        Alteraciones neuropsicológicas en esclerosis múltiple-experiencia Argentina.
        in: García Bonitto En.J.R. Sánchez Múnera. J.L. Guía Neurológica 9. Esclerosis Múltiple. Asociación Colombiana de Neurología (Comité Editorial), Bogotá2008: 147-154
        • Vanotti S.
        • Cores E.V.
        • Eizaguirre B.
        • Melamud L.
        • Rey R.
        • Villa A.
        Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis.
        Arq. Neuropsiquiatr. 2013; 71: 357-361https://doi.org/10.1590/0004-282X20130038
        • Wang Y.
        • Zhang B.
        • Dai Y.
        • Yang Y.
        • Lu Z.
        Cognitive dysfunction and behavioral abnormalities in neuromyelitis optica spectrum disorder: report of a case with cortical gray matter involvement and frontotemporal atrophy.
        Acta Neurol. Belga. 2017; 117: 409-411https://doi.org/10.1007/s13760-016-0685-3
        • Wingerchuk D.M.
        Neuromyelitis spectrum disorders.
        Continuum. 2010; 16: 105-121https://doi.org/10.1212/01.CON.0000389937.69413.15
        • Wingerchuk D.M.
        • Hogancamp W.F.
        • O'Brien P.C.
        • Weinshenker B.G.
        The clinical course of neuromyelitis optica (Devic's syndrome).
        Neurology. 1999; 53: 1107-1114
        • Wingerchuk D.M.
        • Lennon V.A.
        • Pittock S.J.
        • Lucchinetti C.F.
        • Weinshenker B.G.
        Revised diagnostic criteria for neuromyelitis optica.
        Neurology. 2006; 66: 1485-1489
        • Wingerchuk D.M.
        • Lennon V.A.
        • Lucchinetti C.F.
        • Pittock S.J.
        • Weinshenker B.G.
        The spectrum of neuromyelitis optica.
        Lancet Neurol. 2007; 6: 805-815
        • Wingerchuk D.M.
        • Banwell B.
        • Bennett J.L.
        • Cabre P.
        • Carroll W.
        • Chitnis T.
        • International Panel for NMO Diagnosis
        International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
        Neurology. 2015; 85: 177-189https://doi.org/10.1212/WNL.0000000000001729
        • Zhang N.
        • Li Y.J.
        • Fu Y.
        • Shao J.H.
        • Luo L.L.
        • Yang L.
        • Liu Y.
        Cognitive impairment in Chinese neuromyelitis optica.
        Mult. Scler. 2015; 21: 1839-1846https://doi.org/10.1177/1352458515576982
        • Zhao S.
        • Mutch K.
        • Elsone L.
        • Nurmikko T.
        • Jacob A.
        Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life.
        Mult. Scler. 2014; 20: 1658https://doi.org/10.1177/1352458514522103